FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

Two Biotronik Cardiac Rhythm Devices Approved

FDA approves Biotroniks Acticor and Rivacor high-voltage cardiac rhythm management device lines for treating patients with cardiac arrhythmias.

Medical Devices

FDA Approves New Heart Valve Repair Device Indication

FDA approves a new indication for Abbott Vasculars MitraClip mitral valve clip delivery system.

Human Drugs

FDA Steps to Modernize Clinical Trials

FDA commissioner Scott Gottlieb says several new guidances are intended to prod sponsors and clinical research organizations to modernize the clinical...

Medical Devices

BD Venovo Venous Stent Approved

FDA approves a BD (Becton Dickinson) PMA for the Venovo venous stent, indicated for treating iliofemoral venous occlusive disease.

Human Drugs

Guilty Pleas in Fraudulent Supplement Sales Scheme

The Justice Department says five individuals and two companies are pleading guilty to fraudulently marketing two workout and weight loss dietary suppl...

Promoting Unapproved Drugs is OPDP Focus: Analysis

Healthcare communications consultant Mark Senak says the CDER Office of Prescription Drug Promotion is showing an enforcement focus on promotion of un...

Federal Register

Draft Guide on Pediatric Cancer Trial Eligibility

Federal Register notice: FDA makes available a draft guidance entitled Cancer Clinical Trial Eligibility Criteria: Minimum Age for Pediatric Patients....

Biologics

10 Observations on Genetech FDA-483

FDA releases the FDA-483 with 10 observations from an inspection at the Genetech umbilical cord processing facility.

Human Drugs

Purdue on Fast Track for Potential Naloxone Competitor

FDA grants Purdue Pharma a fast track designation for nalmefene hydrochloride injection, an investigational opioid antagonist for the emergency treatm...

Federal Register

Draft Guide on Brain Metastases Trial Eligibility

Federal Register notice: FDA makes available a draft guidance entitled Cancer Clinical Trial Eligibility Criteria: Brain Metastases.